Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-051367
Filing Date
2020-11-05
Accepted
2020-11-05 16:29:11
Documents
80
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q prtk-10q_20200930.htm   iXBRL 10-Q 2544189
2 EX-31.1 prtk-ex311_6.htm EX-31.1 18152
3 EX-31.2 prtk-ex312_9.htm EX-31.2 18316
4 EX-32.1 prtk-ex321_10.htm EX-32.1 6538
5 EX-32.2 prtk-ex322_11.htm EX-32.2 6431
  Complete submission text file 0001564590-20-051367.txt   9195147

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA prtk-20200930.xsd EX-101.SCH 74734
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prtk-20200930_cal.xml EX-101.CAL 51263
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prtk-20200930_def.xml EX-101.DEF 227144
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE prtk-20200930_lab.xml EX-101.LAB 528478
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prtk-20200930_pre.xml EX-101.PRE 386598
11 EXTRACTED XBRL INSTANCE DOCUMENT prtk-10q_20200930_htm.xml XML 1616215
Mailing Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116 (617) 807-6600
Paratek Pharmaceuticals, Inc. (Filer) CIK: 0001178711 (see all company filings)

EIN.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36066 | Film No.: 201290933
SIC: 2834 Pharmaceutical Preparations